Dr Reddys Laboratories

RDY

----

Current ValuationThe current P/E ratio is 39.36, above the reasonable range, cheaper than 2.07% of the time in the past 5 years, and the industry ranks 45/258, the industry Median -1.07.

39.36xP/E

Stock price$14.13Earnings per share$0.36

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

03876114152

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
JNJUSJohnson & Johnson	40.47x	38.06%	$651.32B
NVSUSNOVARTIS AG	30.61x	0.08%	$307.00B
PFEUSPfizer	40.33x	19.28%	$174.81B
RDYUSDr Reddys Laboratories	39.36x	12.08%	$11.77B
AMRXUSAmneal Pharmaceuticals	41.48x	121.20%	$6.53B
IBOUSImpact BioMedical	43.31x	--	$34.26M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.